Provided by Tiger Fintech (Singapore) Pte. Ltd.

VECTUS BIOSYSTEMS LTD

0.048
+0.0012.13%
Volume:5.00K
Turnover:240.00
Market Cap:2.56M
PE:-1.13
High:0.048
Open:0.048
Low:0.048
Close:0.047
Loading ...

Company Profile

Company Name:
VECTUS BIOSYSTEMS LTD
Exchange:
ASX
Establishment Date:
2005
Employees:
- -
Office Location:
26-34 Dunning Avenue,Unit 5, Ground Floor,Rosebery,New South Wales,Australia
Zip Code:
2018
Fax:
61 2 9697 0944
Introduction:
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure. Its lead compound is VB0004, which has potent anti-hypertensive properties, as well as anti-fibrotic activity in the heart and kidneys. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. Vectus Biosystems Limited was founded in 2005 and is based in Rosebery, Australia.